1546
P. Wessig, J. Teubner
LETTER
(10) Moffett, R. B.; Seay, P. H. J. Med. Pharm. Chem. 1960, 2,
201.
(11) (a) Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron
Lett. 1975, 16, 4467. (b) Negishi, E.-I.; Anastasia, L. Chem.
Rev. 2003, 103, 1979. (c) Sonogashira, K. In
H, CH2CH2O), 7.10 (s, 1 H, CHarom). 13C NMR (75 MHz,
CDCl3): d = 13.6, 21.0 (CH3-Carom), 21.1 (CH3-acetate), 24.6
(3-CH2), 27.8 (CH2CH2O), 37.1 (2-CH2), 62.7 (CH2CH2O),
125.9 (CHarom), 132.9, 133.8, 137.8, 140.1, 154.6 (Cq), 171.0
(COOR), 207.8 (RCOR).
Comprehensive Organic Synthesis, Vol. 3; Trost, B. M.;
Fleming, I.; Pattenden, G., Eds.; Pergamon Press: Oxford,
1991, 521–549.
Analytical Data for 2-{1-[(Pivaloyl)oxy]-4,6-dimethyl-3-
oxo-2,3-dihydro-1H-inden-5-yl}ethyl Pivalate (18b).
1H NMR (300 MHz, CDCl3): d = 1.14, 1.17 (s, 9 H, Piv),
2.46 (s, 3H, Me-Carom), 2.51 (dd, J3 = 3.0 Hz, J2 = 18.8 Hz, 1
H, CH2CH), 2.68 (s, 3 H, Me-Carom), 3.03 (t, J3 = 7.7 Hz, 2
H, CH2CH2O), 3.08 (dd, J3 = 7.1 Hz, J2 = 18.8 Hz, 1 H,
CH2CH), 4.10 (t, J3 = 7.7 Hz, 2 H, CH2CH2O), 6.15 (dd,
J3 = 3.0 Hz, J3 = 7.1 Hz, 1 H, CHOPiv), 7.19 (s, 1 H,
CHarom). 13C NMR (75 MHz, CDCl3): d = 13.8, 21.3 (CH3-
(12) (a) Backlund, S. J.; Zweifel, G. J. Am. Chem. Soc. 1977, 99,
3184. (b) 4-(Carboxymethyl)-3,5-dimethylbenzoic Acid
(10).
Compound 9 (1.00 g, 3.78 mmol) in 10 mL dry THF was
cooled to 0 °C and 6.8 mL (6.8 mmol, 1.8 equiv) 1 M BH3–
THF solution was dropped in slowly. After stirring at 0 °C
for 2 h a mixture of 10 mL (0.02 mol, 5 equiv) 2 M NaOH
and 5 mL (0.06 mol, 15 equiv) aq H2O2 solution (30%) was
added. After additional stirring for 2 h further 20 mL of 1 M
NaOH and 50 mL of Et2O were added. The phases were
separated and the aqueous phase was extracted several times
with Et2O. Then the aqueous phase was acidified to pH 1
with HCl and the product was extracted with several portions
of Et2O. The combined organic phases were dried and
evaporated, giving 350 mg (1.68 mmol, 44%) of 10 as a
white solid; mp 285 °C. 1H NMR (300 MHz, DMSO-d6):
d = 2.29 (s, 6 H, 3,5-Me), 3.65 (s, 2 H, CH2), 7.59 (s, 2 H,
CHarom). 13C NMR (75 MHz, DMSO-d6): d = 19.8 (3,5-Me),
35.2 (CH2), 128.5 (CHarom), 128.8, 137.3, 137.9 (Cq), 167.4,
171.8 (COOH). IR (KBr): 2959 (br s), 2923 (s), 2858 (s),
1718 (s), 1667 (s), 1425 (s), 1413 (s), 1303 (s), 1244 (s),
1230 (s), 1182 (m). HRMS (ESI): m/z calcd for C11H13O4
[MH+]: 209.0808. Found: 209.0809.
Carom), 27.0, 27.1 (CH3, Piv), 28.0 (CH2CH2O), 38.6, 38.6
(Cq, Piv), 44.6 (2-CH2), 62.3 (CH2CH2O), 68.5 (3-CH), 73.2
(CH2O), 125.4 (CHarom), 132.8, 136.7, 137.5, 145.1, 151.0
(Cq), 178.5, 178.6 (COOR), 202.9 (RCOR). IR (film): 2973
(s), 1717 (vs), 1599 (s), 1478 (s), 1458 (s), 1396 (s), 1281 (s),
1148 (s), 1033 (s), 1010 (s), 984 (m). HRMS (ESI): m/z calcd
for C23H33O5 [MH+]: 389.2323; found: 389.2324.
(18) (a) Greene, T. W.; Wuts, P. G. M. Protective Groups in
Organic Synthesis, 3rd ed.; Wiley-Interscience: New York,
1999, 171. (b) Kosmol, H.; Hill, F.; Kerb, U.; Kieslich, K.
Tetrahedron Lett. 1970, 11, 641. (c) Poijärvi, P.; Orivanen,
M.; Lönnberg, H. Lett. Org. Chem. 2004, 1, 183.
(19) Experimental Procedure for 3-Hydroxy-6-(2-
hydroxyethyl)-5,7-dimethyl-1-indanone (22).
To a solution of 65 mg (0.17 mmol) 18b in 10 mL DMSO
was added a mixture of 100 mL 0.01 M aq HEPES buffer
solution (pH 7.5, I = 0.1 M NaCl) and 90 mg (2160 units)
porcine liver esterase (EC 3.1.1.1, Sigma). The mixture was
stirred 2 d at r.t. in which the reaction course was monitored
by HPLC analysis (see below). After complete
saponification of both ester groups the mixture was treated
with 50 mL CH2Cl2, filtrated and the phases were separated.
The organic phase was dried with MgSO4, evaporated and
purified by FCC (CH2Cl2–MeOH, 10:1, Rf = 0.39) affording
20.0 mg (90.8 µmol, 54%) 22 as a white solid.
(13) Muraki, T.; Togo, H.; Yokoyama, M. J. Org. Chem. 1999,
64, 2883.
(14) Mizushima, E.; Sato, K.; Hayashi, T.; Tanaka, M. Angew.
Chem. Int. Ed. 2002, 114, 4563.
(15) (a) Koser, G. F.; Relenyi, A. G.; Kalos, A. N.; Rebrovic, L.;
Wettach, R. H. J. Org. Chem. 1982, 47, 2487. (b) Lodaya,
J. S.; Koser, G. F. J. Org. Chem. 1988, 53, 210.
(16) (a) Bergmark, W. R. J. Chem. Soc., Chem. Commun. 1978,
61. (b) Bergmark, W. R.; Barnes, C.; Clark, J.; Paparian, S.;
Marynowski, S. J. Org. Chem. 1985, 50, 5612.
HPLC conditions: column: Eurospher 100 C-18 (Knauer),
5 mm, 250 × 4 mm; mobile phase: gradient MeOH–H2O
(70:30 → 90:10) linear in 20 min, then 90:10 flow: 1 mL/
min. peaks: tR(22) = 2.6 min, tR(18b) = 31.9 min.
(c) Favorskii, A. J. Russ. Phys. Chem. Soc. 1905, 37, 643.
(d) Kende, A. S. Org. React. 1960, 11, 261.
(17) Irradiation of 17a and 17b.
Mp 143–145 °C. 1H NMR (300 MHz, DMSO-d6): d = 2.34
(dd, J3 = 3.0 Hz, J2 = 18.5 Hz, 1 H, CH2CH), 2.40, 2.56 (s, 3
H, Me-Carom), 2.84 (t, J3 = 7.5 Hz, 2 H, CH2CH2OH), 2.90
(dd, J3 = 7.0 Hz, J2 = 18.5 Hz, 1 H, CH2CH), 3.41–3.46 (m,
2 H, CH2CH2OH), 4.78 (t, J3 = 5.5 Hz, 1 H, CH2OH), 5.02–
5.06 (m, 1 H, 3-CH), 5.57 (d, J3 = 6.0 Hz, 1 H, OH), 7.31 (s,
1 H, CHarom). 13C NMR (75 MHz, DMSO-d6): d = 13.3, 21.0
(CH3-Carom), 32.1 (CH2CH2OH), 47.7 (2-CH2), 59.8
(CH2CH2OH), 65.6 (3-CH), 125.0 (CHarom), 131.5, 135.6,
137.1, 144.2, 155.6 (Cq), 204.3 (RCOR). IR (KBr): 3391 (br
s), 2923 (m), 1687 (vs), 1596 (s), 1408 (m), 1326 (m), 1308
(s), 1260 (m), 1065 (s), 1025 (s), 804 (m). HRMS (ESI):
m/z calcd for C13H17O3 [MH+]: 221.1172; found: 221.1173.
For solvents, conditions and yields see Table 1. The
irradiation was performed in a 500 mL reactor vessel,
equipped with a 150 W high-pressure mercury arc lamp (TQ
150, Heraeus) and monitored by TLC. The solvent was
removed in vacuo and the residue was purified by flash
chromatography.
Analytical Data for 2-(4,6-Dimethyl-3-oxo-2,3-dihydro-
1H-inden-5-yl)ethyl Acetate (18a).
Mp 39–41 °C. 1H NMR (300 MHz, CDCl3): d = 2.03 (s, 3 H,
CH3-acetate), 2.42 (s, 3 H, Me-Carom), 2.60–2.64 (m, 2 H, 2-
CH2), 2.67 (s, 3 H, Me-Carom), 2.94–2.98 (m, 2 H, 3-CH2),
3.03 (t, J3 = 7.7 Hz, 2 H, CH2CH2O), 4.12 (t, J3 = 7.7 Hz, 2
Synlett 2006, No. 10, 1543–1546 © Thieme Stuttgart · New York